Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One decade of 'Bench-to-Bedside' peptide receptor radionuclide therapy with indigenous [177Lu]Lu-DOTATATE obtained through 'Direct' neutron activation route: lessons learnt including practice evolution in an Indian setting.
Basu S, Chakraborty S, Parghane RV, Kamaldeep, Ranade R, Thapa P, Asopa RV, Sonawane G, Nabar S, Shimpi H, Chandak A, Vimalnath KV, Ostwal V, Ramaswamy A, Bhandare M, Chaudhari V, Shrikhande SV, Sirohi B, Dash A, Banerjee S. Basu S, et al. Among authors: shimpi h. Am J Nucl Med Mol Imaging. 2020 Aug 25;10(4):178-211. eCollection 2020. Am J Nucl Med Mol Imaging. 2020. PMID: 32929396 Free PMC article. Review.
Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting.
Basu S, Kand P, Mallia M, Korde A, Shimpi H. Basu S, et al. Among authors: shimpi h. Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1622-4. doi: 10.1007/s00259-013-2501-0. Epub 2013 Jul 16. Eur J Nucl Med Mol Imaging. 2013. PMID: 23857460 No abstract available.
'Reverse discordance' between 68Ga-DOTA-NOC PET/CT and 177Lu-DOTA-TATE posttherapy scan: the plausible explanations and its implications for high-dose therapy with radiolabeled somatostatin receptor analogs.
Basu S, Abhyankar A, Kand P, Kumar R, Asopa R, Rajan MG, Nayak U, Shimpi H, Das T, Venkatesh M, Chakrabarty S, Banerjee S. Basu S, et al. Among authors: shimpi h. Nucl Med Commun. 2011 Jul;32(7):654-8. doi: 10.1097/MNM.0b013e328346350f. Nucl Med Commun. 2011. PMID: 21654355
Preparation of [186Re]Re-DMSA and its bio-distribution studies.
Kothari K, Pillai MR, Unni PR, Shimpi HH, Noronha OP, Samuel AM. Kothari K, et al. Among authors: shimpi hh. Appl Radiat Isot. 1999 Jul;51(1):43-9. doi: 10.1016/s0969-8043(98)00194-8. Appl Radiat Isot. 1999. PMID: 10376320
11 results